Under the framework, the facility of algo trading would be provided by the stockbroker to retail investors only after obtaining permission of the stock exchange for each algo.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.